BFEC
AGN

Benjamin F. Edwards & Company’s Allergan plc AGN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,522
Closed -$624K – 1852
2020
Q1 		$624K Sell
3,522
-478
-12% -$90K 0.05% 301
2019
Q4 		$765K Sell
4,000
-487
-11% -$87.9K 0.05% 311
2019
Q3 		$755K Buy
4,487
+99
+2% +$16.1K 0.06% 301
2019
Q2 		$735K Sell
4,388
-970
-18% -$134K 0.06% 299
2019
Q1 		$784K Buy
5,358
+2,867
+115% +$416K 0.07% 266
2018
Q4 		$333K Buy
2,491
+278
+13% +$45.6K 0.03% 374
2018
Q3 		$421K Sell
2,213
-166
-7% -$30.5K 0.04% 357
2018
Q2 		$397K Buy
2,379
+1,877
+374% +$301K 0.04% 367
2018
Q1 		$85K Sell
502
-1,190
-70% -$200K 0.01% 722
2017
Q4 		$277K Buy
1,692
+959
+131% +$172K 0.03% 415
2017
Q3 		$150K Buy
733
+226
+45% +$52.6K 0.02% 519
2017
Q2 		$123K Sell
507
-115
-18% -$27K 0.02% 531
2017
Q1 		$149K Sell
622
-87
-12% -$20.3K 0.02% 471
2016
Q4 		$149K Buy
709
+500
+239% +$104K 0.02% 428
2016
Q3 		$48K Buy
209
+125
+149% +$30.5K 0.01% 547
2016
Q2 		$19K Buy
84
+12
+17% +$2.77K ﹤0.01% 683
2016
Q1 		$19K Hold
72
– – ﹤0.01% 687
2015
Q4 		$23K Sell
72
-478
-87% -$142K 0.01% 663
2015
Q3 		$149K Sell
550
-42
-7% -$12.9K 0.03% 348
2015
Q2 		$180K Buy
592
+125
+27% +$37.3K 0.04% 358
2015
Q1 		$139K Buy
467
+199
+74% +$56.7K 0.03% 388
2014
Q4 		$69K Buy
268
+188
+235% +$47K 0.02% 459
2014
Q3 		$19K Hold
80
– – ﹤0.01% 667
2014
Q2 		$18K Hold
80
– – ﹤0.01% 640
2014
Q1 		$16K Buy
80
+30
+60% +$5.94K ﹤0.01% 624
2013
Q4 		$8K Hold
50
– – ﹤0.01% 693
2013
Q3 		$7K Hold
50
– – ﹤0.01% 668
2013
Q2 		$6K Buy
+50
New +$5.66K ﹤0.01% 655

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Benjamin F. Edwards & Company's AGN Position: Q2 2020 in Review

Benjamin F. Edwards & Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,522 shares — an estimated $624K sold.

Benjamin F. Edwards & Company first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $784K in Q1 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Benjamin F. Edwards & Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 3,522 Allergan plc shares in Q2 2020, an estimated $624K.
  • Benjamin F. Edwards & Company first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Benjamin F. Edwards & Company's Allergan plc position peaked at $784K in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2020, filed 14 Aug 2020.